Suppr超能文献

意大利多中心病例系列中甲状旁腺非典型腺瘤和癌的复发率和死亡率。

Recurrence and mortality rate in an Italian multi-center case series of parathyroid atypical adenomas and carcinomas.

机构信息

Division of Endocrinology, Diabetology and Metabolic Diseases, Department of Medical Sciences, Città Della Salute e Della Scienza Hospital, University of Turin - Cso Dogliotti, Turin, Italy.

Oncological Endocrinology Unit, Department of Medical Sciences, Città Della Salute e Della Scienza Hospital, University of Turin - Via Genova, Turin, Italy.

出版信息

Front Endocrinol (Lausanne). 2023 May 8;14:1158474. doi: 10.3389/fendo.2023.1158474. eCollection 2023.

Abstract

INTRODUCTION

There are few data regarding the clinical outcome of patients with parathyroid carcinoma (PC) and atypical adenoma (AA) after surgery. Aim of our study was to investigate disease recurrence and mortality rate as well as their predictors in a series of patients with PC or AA.

METHODS

Clinical and biochemical parameters, histological features, incidence of disease recurrence and mortality rate were retrospectively assessed in 39 patients (51% males, mean age 56.2 ± 17.2 years) diagnosed with PC (n=24) or AA (n=15) and followed up for 6.8 ± 5.0 years after surgery.

RESULTS

No differences in baseline characteristics were registered between the two groups, except for higher KI67 values in PC than AA (6.9 ± 3.9% vs 3.4 ± 2.1%, p<0.01). Eight patients (21%) experienced recurrence after a mean follow-up of 5.1 ± 2.7 years, with higher relapse rate in PC than AA (25% vs 13%), though this difference did not reach statistical significance. Mortality rate was 10% in the whole sample, without significant differences between PC and AA. Relapsing cases had been undergone the most extensive surgery more frequently and they had a higher mortality rate in comparison to non relapsing patients (38% vs 6% and 38% vs 3%, respectively, p<0.03 for both). In comparison to survivors, deceased patients were submitted to the most extensive surgery more frequently (50% vs 9%), they were older (74.8 ± 4.6 vs 53.2 ± 16.3 years), and they had higher KI67 values (11.7 ± 4.9 vs 4.8 ± 2.8, p<0.03 for all comparisons).

CONCLUSIONS

During seven-year follow-up after surgery, no significant differences in recurrence and mortality rate were observed between PC and AA patients. Death was associated with disease relapse, older age and higher KI67 values. These findings suggest a similar and careful long-term follow-up in both parathyroid tumors, especially in older patients, and emphasize the need of further studies in large cohorts to throw light on this crucial clinical issue.

摘要

简介

关于甲状旁腺癌(PC)和非典型腺瘤(AA)患者手术后的临床转归数据较少。本研究旨在调查一系列 PC 或 AA 患者手术后疾病复发和死亡率及其预测因素。

方法

回顾性评估了 39 例(男性 51%,平均年龄 56.2 ± 17.2 岁)PC(n=24)或 AA(n=15)患者的临床和生化参数、组织学特征、疾病复发率和死亡率,这些患者在手术后随访 6.8 ± 5.0 年。

结果

两组间基线特征无差异,除了 PC 患者的 KI67 值高于 AA(6.9 ± 3.9%比 3.4 ± 2.1%,p<0.01)。8 例(21%)患者在平均 5.1 ± 2.7 年的随访后出现复发,PC 患者的复发率高于 AA(25%比 13%),但差异无统计学意义。全组死亡率为 10%,PC 和 AA 之间无显著差异。复发患者较无复发患者更频繁地接受最广泛的手术,死亡率更高(38%比 6%和 38%比 3%,均 p<0.03)。与幸存者相比,死亡患者更频繁地接受最广泛的手术(50%比 9%),年龄更大(74.8 ± 4.6 岁比 53.2 ± 16.3 岁),KI67 值更高(11.7 ± 4.9 比 4.8 ± 2.8,所有比较均 p<0.03)。

结论

在手术后 7 年的随访中,PC 和 AA 患者的复发率和死亡率无显著差异。死亡与疾病复发、年龄较大和 KI67 值较高有关。这些发现表明,在这两种甲状旁腺肿瘤中,尤其是在老年患者中,需要进行类似的、仔细的长期随访,并强调需要在更大的队列中进行进一步的研究,以阐明这一关键的临床问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fb0/10200939/1747cfad31b8/fendo-14-1158474-g001.jpg

相似文献

1
Recurrence and mortality rate in an Italian multi-center case series of parathyroid atypical adenomas and carcinomas.
Front Endocrinol (Lausanne). 2023 May 8;14:1158474. doi: 10.3389/fendo.2023.1158474. eCollection 2023.
2
Parathyroid carcinoma and atypical parathyroid tumor: analysis of an Italian database.
Eur J Endocrinol. 2024 Sep 30;191(4):416-425. doi: 10.1093/ejendo/lvae121.
3
A nationwide study on parathyroid carcinoma.
Acta Oncol. 2017 Jul;56(7):991-1003. doi: 10.1080/0284186X.2017.1306103. Epub 2017 Mar 31.
4
Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism.
Langenbecks Arch Surg. 2016 Nov;401(7):943-951. doi: 10.1007/s00423-015-1361-4. Epub 2015 Dec 11.
5
Oxyphil parathyroid carcinomas: a clinicopathologic and immunohistochemical study of 10 cases.
Am J Surg Pathol. 2002 Mar;26(3):344-9. doi: 10.1097/00000478-200203000-00008.
6
Clinical and genetic analysis of atypical parathyroid adenoma compared with parathyroid carcinoma and benign lesions in a Chinese cohort.
Front Endocrinol (Lausanne). 2023 Jan 26;14:1027598. doi: 10.3389/fendo.2023.1027598. eCollection 2023.
7
Modern experience with aggressive parathyroid tumors in a high-volume New England referral center.
J Am Coll Surg. 2015 Jun;220(6):1054-62. doi: 10.1016/j.jamcollsurg.2014.10.007. Epub 2014 Oct 24.
9
Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis?
Cancer. 2007 Jul 15;110(2):255-64. doi: 10.1002/cncr.22790.
10
Immunohistochemical Expression of E-Cadherin in Atypical Parathyroid Adenoma.
World J Surg. 2015 Oct;39(10):2477-83. doi: 10.1007/s00268-015-3149-7.

引用本文的文献

1
Transcriptome sequencing reveals distinct atypical parathyroid tumor subtypes.
Endocr Relat Cancer. 2025 Jun 14;32(6). doi: 10.1530/ERC-25-0057. Print 2025 Jun 1.

本文引用的文献

1
Clinical and genetic analysis of atypical parathyroid adenoma compared with parathyroid carcinoma and benign lesions in a Chinese cohort.
Front Endocrinol (Lausanne). 2023 Jan 26;14:1027598. doi: 10.3389/fendo.2023.1027598. eCollection 2023.
2
Overview of the 2022 WHO Classification of Parathyroid Tumors.
Endocr Pathol. 2022 Mar;33(1):64-89. doi: 10.1007/s12022-022-09709-1. Epub 2022 Feb 17.
3
Do Patients With Atypical Parathyroid Adenoma Need Close Follow-up?
J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4565-e4579. doi: 10.1210/clinem/dgab452.
4
Atypical parathyroid adenoma: clinical and anatomical pathologic features.
World J Surg Oncol. 2021 Jan 20;19(1):19. doi: 10.1186/s12957-021-02123-7.
5
Distinguishing Parathyromatosis, Atypical Parathyroid Adenomas, and Parathyroid Carcinomas Utilizing Histologic and Clinical Features.
Head Neck Pathol. 2021 Sep;15(3):727-736. doi: 10.1007/s12105-020-01281-6. Epub 2021 Jan 4.
6
Parathyroid Carcinoma: An Up-to-Date Retrospective Multicentric Analysis.
Int J Endocrinol. 2020 Mar 6;2020:7048185. doi: 10.1155/2020/7048185. eCollection 2020.
7
Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors.
Endocr Relat Cancer. 2019 Jul;26(7):R441-R464. doi: 10.1530/ERC-19-0135.
8
Parathyroid Carcinoma.
Front Horm Res. 2019;51:63-76. doi: 10.1159/000491039. Epub 2018 Nov 19.
9
Parathyroid carcinoma.
Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):877-889. doi: 10.1016/j.beem.2018.11.002. Epub 2018 Dec 1.
10
Parathyroid carcinoma: a clinical and genetic perspective.
Minerva Endocrinol. 2018 Jun;43(2):144-155. doi: 10.23736/S0391-1977.17.02737-7. Epub 2017 Sep 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验